Finance

Lists
Q2 2026 earnings • released • EPS beat +55.84% • Revenue beat +3.88%
See results
MRVI:NASDAQ
Maravai Lifesciences Holdings Inc
$6.23
-0.32%
(-0.020) 1D
$6.12
-1.77% (-0.11)
After hours
Closed: Aug 7, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MRVI...
Open
$5.60
High
$6.26
Low
$5.41
Mkt. cap
1.61B
Avg. vol.
2.87M
Volume
4.08M
52-wk high
$7.44
52-wk low
$2.02
EPS
-$0.72
Beta
0.64
Shares outstanding
147.51M
No. of employees
416
Open
$5.60
High
$6.26
Low
$5.41
Mkt. cap
1.61B
Avg. vol.
2.87M
Volume
4.08M
52-wk high
$7.44
52-wk low
$2.02
EPS
-$0.72
Beta
0.64
Shares outstanding
147.51M
No. of employees
416
News stories
From sources across the web
About Maravai Lifesciences Holdings Inc
CEO-
Employees416
Founded2014
Headquarters-
SectorHealth care
Websitemaravai.com
Analyst ratings
Based on 4 analysts giving stock ratings to MRVI in the past 3 months
Buy
Buy
2
Hold
2
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for MRVI in the last 3 months.
Highest
Current $6.23
$6.50 (+4.33%)
Average
$6.25 (+0.32%)
Lowest
$6.00 (-3.69%)
Analyst
Recommendation
Action
Price target
Projected
Date
Unknown Analyst
Wells Fargo
Buy
Maintained
$6.50
+4.3%
08/07/2026
Matt Larew
William Blair
Hold
Reiterated
-
-
08/07/2026
Daniel Arias
Stifel Nicolaus
Buy
Maintained
$6.00
-3.7%
05/11/2026
Subbu Nambi
Guggenheim
Hold
Maintained
-
-
05/11/2026
Justin Bowers
Deutsche Bank
Buy
Maintained
$6.00
-3.7%
05/08/2026
Matt Hewitt
Craig-Hallum
Buy
Reiterated
$5.00
-19.7%
05/08/2026
Catherine Ramsey Schulte
Robert W. Baird
Hold
Maintained
$3.00
-51.8%
02/26/2026
Unknown Analyst
Jefferies
Buy
Reiterated
$5.00
-19.7%
02/26/2026
Last report
Aug 6, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
-$0.02 / -$0.05
+55.84%beat
Revenue / Est. (USD)
51.44M / 49.52M
+3.88%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
41.63M
49.87M
65.84M
51.44M
Cost of goods sold
35.98M
35.32M
32.14M
30.79M
Cost of revenue
35.98M
35.32M
32.14M
30.79M
Research and development expenses
3.84M
3.79M
3.89M
3.70M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
35.40M
30.38M
29.09M
32.07M
Operating expense
39.24M
34.17M
32.98M
35.77M
Total operating expenses
75.22M
69.50M
65.12M
66.56M
Operating income
-33.58M
-19.63M
720.00K
-15.12M
Other non operating income
-71.00K
-43.00K
-494.00K
-52.00K
EBT including unusual items
-45.15M
-63.01M
-6.53M
-21.80M
EBT excluding unusual items
-37.70M
-23.84M
-3.65M
-18.82M
Income tax expense
-92.00K
6.00K
-151.00K
-171.00K
Effective tax rate
0.20%
-0.01%
2.31%
0.78%
Other operating expenses
-
-
-
-
Net income
-25.56M
-35.68M
-3.73M
-12.42M
Net profit margin
-61.39%
-71.55%
-5.67%
-24.14%
Earnings per share
-0.08
-0.04
0.01
-0.02
Interest and investment income
2.80M
2.38M
1.87M
1.16M
Interest expense
-6.84M
-6.56M
-5.75M
-4.81M
Net interest expenses
-4.05M
-4.17M
-3.88M
-3.65M
Depreciation and amortization charges
-
-
-
-
EBITDA
-20.40M
-7.18M
12.09M
-3.75M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps